Cushing disease

What is Cushing disease?

Cushing disease is a rare endocrine disorder caused by a benign tumor (adenoma) in the pituitary gland that produces excessive amounts of adrenocorticotropic hormone (ACTH). This excess ACTH stimulates the adrenal glands to overproduce cortisol, leading to a constellation of symptoms including weight gain, high blood pressure, and distinctive physical changes. The condition affects approximately 1.2-2.4 people per million each year, making it one of the rarer causes of Cushing syndrome. While challenging to diagnose due to its subtle early symptoms, proper recognition and treatment can significantly improve outcomes and quality of life for patients.

Key statistics

Symptoms

Primary symptoms: Central obesity, moon-shaped face, purple stretch marks, high blood pressure, muscle weakness, easy bruising, slow wound healing, mood changes, irregular menstruation, decreased fertility.

The symptoms of Cushing disease develop gradually due to prolonged exposure to excess cortisol. Early symptoms often include unexplained weight gain concentrated in the trunk and face, fatigue, and mood changes such as depression or irritability. Patients may notice their face becoming rounder (moon facies) and develop a fatty hump between the shoulders.

Physical manifestations become more pronounced over time, including wide purple or pink stretch marks (striae) on the abdomen, thighs, or arms that are distinctly different from typical stretch marks. The skin becomes thin and fragile, leading to easy bruising and slow healing of cuts or wounds. Muscle weakness, particularly in the arms and legs (proximal myopathy), makes it difficult to climb stairs or rise from a chair.

Submit Your Paper

Metabolic symptoms include high blood pressure, diabetes or glucose intolerance, and osteoporosis leading to bone fractures. Women may experience irregular or absent menstrual periods, while men may develop erectile dysfunction and decreased libido. Psychological symptoms can be severe, including depression, anxiety, cognitive difficulties, and in some cases, psychosis.

Causes and risk factors

Cushing disease is caused by a benign pituitary adenoma that secretes excess ACTH. Unlike many rare diseases, Cushing disease is not inherited and occurs sporadically in most cases. The exact cause of these pituitary tumors is unknown, but they arise from mutations in the corticotroph cells of the anterior pituitary gland.

Most cases are sporadic, meaning they occur randomly without a family history. However, rarely, Cushing disease can be associated with genetic syndromes such as multiple endocrine neoplasia type 1 (MEN1) or familial isolated pituitary adenoma (FIPA). These hereditary forms account for less than 5% of all cases.

Risk factors are not well-established for sporadic cases. There is no clear association with environmental exposures, infections, or lifestyle factors. The higher prevalence in women of reproductive age suggests hormonal influences may play a role, but this relationship is not fully understood.

Prevention

There is no known prevention for Cushing disease since most cases occur sporadically without identifiable risk factors. Because the condition is not typically inherited, routine genetic screening is not recommended for the general population.

For the rare families with hereditary forms associated with MEN1 or FIPA syndromes, genetic counseling and testing may be appropriate for family members. However, even in these cases, having the genetic mutation does not guarantee the development of Cushing disease, as penetrance is variable.

Early recognition of symptoms and prompt medical evaluation represent the best approach to minimize complications through timely diagnosis and treatment.

Complications

Without treatment, Cushing disease can lead to serious, life-threatening complications. The persistently elevated cortisol levels affect multiple organ systems, significantly increasing morbidity and mortality.

Cardiovascular complications include severe hypertension, heart disease, and increased risk of heart attacks and strokes. Metabolic consequences encompass diabetes mellitus, severe osteoporosis with increased fracture risk, and muscle wasting that can severely impair mobility.

Infectious complications arise from cortisol’s immunosuppressive effects, leading to increased susceptibility to infections and delayed wound healing. Psychiatric complications can be severe, including treatment-resistant depression, cognitive impairment, and in extreme cases, suicidal ideation.

Reproductive complications affect both men and women, causing infertility, decreased libido, and in women, menstrual irregularities. Growth retardation occurs in children with the condition.

The overall mortality rate is 2-5 times higher than the general population when left untreated, primarily due to cardiovascular and infectious complications.

Diagnosis

Diagnosing Cushing disease requires a systematic approach combining clinical evaluation, biochemical testing, and imaging studies. The diagnostic process can be lengthy and complex, often taking months to years due to the gradual onset of symptoms and their overlap with more common conditions.

Initial screening tests include 24-hour urine free cortisol measurement, late-night salivary cortisol tests, and the dexamethasone suppression test. These tests confirm the presence of excess cortisol production.

Differential diagnosis involves distinguishing Cushing disease from other causes of Cushing syndrome. The high-dose dexamethasone suppression test and measurement of ACTH levels help differentiate pituitary from adrenal causes. Corticotropin-releasing hormone (CRH) stimulation tests may provide additional diagnostic information.

Imaging studies include pituitary MRI to identify and localize the adenoma. However, up to 40% of pituitary adenomas may be too small to detect on routine MRI. In cases where imaging is negative but biochemical evidence strongly suggests Cushing disease, inferior petrosal sinus sampling may be performed to confirm the pituitary source of excess ACTH.

Additional tests may include comprehensive metabolic panels, bone density scans, and cardiovascular evaluations to assess complications.

Treatment

Treatment of Cushing disease primarily involves surgical removal of the pituitary adenoma, but medical therapies play important roles in specific situations.

Surgical treatment remains the first-line therapy. Transsphenoidal surgery, performed through the nose to reach the pituitary gland, is the preferred approach. This minimally invasive technique has cure rates of 70-90% for experienced surgeons, depending on tumor size and location.

Medical therapies are used when surgery is not possible, has failed, or as a bridge to surgery. FDA-approved medications include ketoconazole and metyrapone, which inhibit cortisol synthesis. Osilodrostat is a newer cortisol synthesis inhibitor with improved efficacy and tolerability.

Pasireotide, a somatostatin analog, targets the pituitary adenoma directly and can suppress ACTH secretion. Mifepristone, a glucocorticoid receptor antagonist, blocks cortisol action at the tissue level and is particularly useful for patients with diabetes and psychiatric symptoms.

Radiation therapy may be considered for patients with persistent disease after surgery or those who cannot undergo surgical intervention. Stereotactic radiosurgery offers more precise targeting but may take years to achieve full effect.

Bilateral adrenalectomy represents a last resort option that immediately corrects hypercortisolism but requires lifelong hormone replacement therapy.

Prognosis

The prognosis for Cushing disease varies significantly depending on the timing of diagnosis and treatment success. With prompt recognition and appropriate treatment, many patients can achieve remission and experience substantial improvement in symptoms and quality of life.

Surgical outcomes show cure rates of 70-90% for first-time transsphenoidal surgery when performed by experienced neurosurgeons. Remission rates are higher for smaller tumors and those not invading surrounding structures. However, recurrence can occur in 10-20% of patients over 10 years, necessitating long-term follow-up.

Recovery timeline varies among patients. Some symptoms, such as psychiatric manifestations and muscle weakness, may improve within weeks to months. However, physical changes like central obesity, striae, and bone density may take years to improve or may be permanent.

Long-term complications can persist even after successful treatment. Cardiovascular disease, diabetes, and osteoporosis may require ongoing management. Some patients develop hypopituitarism requiring hormone replacement therapy.

Quality of life generally improves significantly after successful treatment, though some patients report persistent fatigue, mood issues, or cognitive difficulties. Early diagnosis and treatment are associated with better long-term outcomes.

Quality of life

Living with Cushing disease significantly impacts daily life, but understanding and addressing these challenges can help patients maintain the best possible quality of life during treatment and recovery.

Physical adaptations may be necessary due to muscle weakness and fatigue. Patients should pace activities, use assistive devices when needed, and gradually increase activity levels as strength improves. Regular, gentle exercise as tolerated can help maintain muscle mass and bone density.

Dietary considerations include managing diabetes or glucose intolerance through a balanced, low-sugar diet. Adequate calcium and vitamin D intake supports bone health. Limiting sodium helps control blood pressure and fluid retention.

Mental health support is crucial, as depression and anxiety are common. Professional counseling, support groups, and sometimes psychiatric medication can provide significant benefits. Family members should understand that mood changes are part of the disease, not character flaws.

Sleep hygiene becomes important as cortisol excess can disrupt normal sleep patterns. Maintaining regular sleep schedules and creating a calm bedtime environment can help.

Work and social adjustments may be needed during active disease and recovery. Some patients require temporary disability or workplace accommodations. Open communication with employers and family members about limitations and needs is beneficial.

Pregnancy and fertility

Cushing disease significantly affects reproductive health in both men and women. Excess cortisol suppresses the reproductive hormone axis, leading to decreased fertility and menstrual irregularities in women and reduced testosterone and libido in men.

Pregnancy considerations are complex. Active Cushing disease during pregnancy carries risks for both mother and fetus, including gestational diabetes, hypertension, preterm birth, and low birth weight. However, pregnancy outcomes can improve significantly after successful treatment.

Medication safety during pregnancy varies by drug. Metyrapone is generally considered the safest medical therapy during pregnancy, while other medications may pose risks to the developing fetus. Surgical treatment during pregnancy is possible but typically reserved for severe cases during the second trimester.

Fertility recovery often occurs after successful treatment of Cushing disease, though the timeline varies. Some women resume normal menstruation within months, while others may take longer to restore reproductive function.

Genetic counseling is recommended for patients with hereditary forms of Cushing disease, though these represent a small minority of cases.

Children

Cushing disease in children is extremely rare but presents unique challenges. Pediatric cases may show different symptoms compared to adults, with growth retardation being a prominent feature alongside obesity and delayed puberty.

Diagnostic considerations in children require age-specific reference ranges for cortisol testing and careful evaluation of growth patterns. The psychological impact can be particularly severe during formative years, affecting self-esteem and social development.

Treatment approaches are similar to adults, with transsphenoidal surgery remaining the first-line therapy. However, medication dosing requires careful adjustment for weight and development stage. Long-term follow-up is crucial to monitor for pituitary hormone deficiencies that may affect growth and puberty.

Educational support may be needed as cognitive symptoms and frequent medical appointments can impact school performance. Coordination between medical teams, families, and schools helps ensure optimal outcomes.

When to see a doctor

Urgent medical attention is needed for signs of severe complications including severe depression with suicidal thoughts, signs of serious infection, severe muscle weakness affecting mobility, or cardiovascular emergencies.

Routine evaluation should be sought for the gradual development of multiple symptoms including unexplained weight gain concentrated in the trunk and face, development of wide purple stretch marks, easy bruising, muscle weakness, persistent high blood pressure, mood changes, or irregular menstruation in women.

Follow-up care is essential for patients with diagnosed Cushing disease, even after successful treatment, to monitor for recurrence and manage long-term complications.

The combination of multiple symptoms, particularly when occurring together in a previously healthy individual, warrants endocrinological evaluation even when individual symptoms might seem common.

Regional context

Specific prevalence data for Cushing disease in the Caucasus region (Georgia, Armenia, Azerbaijan) and Eastern Mediterranean are limited. The global incidence of 1.2-2.4 per million annually likely applies to these regions, though genetic factors, environmental influences, or healthcare access might create regional variations.

We invite medical professionals and researchers from these regions to contribute their experiences and data to the Global Medical Journal to better understand the regional epidemiology and clinical patterns of Cushing disease in these populations.

Regional healthcare systems may face unique challenges in diagnosing and treating this rare condition, including access to specialized endocrinological care and advanced imaging technologies necessary for proper evaluation.

Research and clinical trials

Current research focuses on improving diagnostic methods, developing more effective medical therapies, and understanding the long-term consequences of the disease and its treatment.

Emerging therapies include new cortisol synthesis inhibitors, novel somatostatin analogs, and targeted therapies based on improved understanding of pituitary adenoma biology. Research into the genetic basis of sporadic pituitary adenomas may lead to personalized treatment approaches.

Diagnostic innovations aim to develop more sensitive and specific tests for early detection and monitoring treatment response. Advanced imaging techniques and molecular markers are under investigation.

Quality of life research examines long-term outcomes after treatment and develops interventions to address persistent symptoms and complications.

Patients interested in clinical trials can search for relevant studies at ClinicalTrials.gov or consult with their endocrinologists about available research opportunities. Participation in clinical trials not only provides access to potentially beneficial treatments but also contributes to advancing knowledge for future patients.

Frequently asked questions

Is Cushing disease the same as Cushing syndrome?

No, Cushing disease is a specific type of Cushing syndrome caused by a pituitary adenoma. Cushing syndrome refers to any condition causing excess cortisol, including adrenal tumors, medications, or other sources.

Can Cushing disease be inherited?

Most cases are sporadic and not inherited. Rarely, it can be associated with hereditary syndromes like MEN1, but these account for less than 5% of cases.

How long does it take to recover after surgery?

Recovery varies significantly. Some symptoms like mood and muscle weakness may improve within weeks to months, while physical changes may take years to resolve or may be permanent.

Will I need medication for life after surgery?

Not necessarily. If surgery is successful and doesn’t damage normal pituitary function, many patients don’t require long-term medication. However, some patients may need hormone replacement therapy if pituitary function is affected.

Can stress cause Cushing disease?

No, psychological stress does not cause Cushing disease. However, the high cortisol levels in Cushing disease can worsen the body’s response to stress and affect mood significantly.

Support and resources

Patient organizations:
– Cushing’s

Licensed under CC BY 4.0. Free to share with attribution to GMJ News.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.